SOPHiA GENETICS (SOPH) EBITDA Margin (2020 - 2025)
SOPHiA GENETICS (SOPH) reported EBITDA Margin of 85.3% for Q4 2025, down 3426.0% on a YoY basis from 2.56% in Q4 2024, and up 7.06% sequentially from 91.78% in Q3 2025.
SOPHiA GENETICS (SOPH) EBITDA Margin (2020 - 2025) Analysis & Trends
SOPHiA GENETICS (SOPH) has 6 years of EBITDA Margin data on file, last reported at 85.3% in Q4 2025.
- For the quarter ending Q4 2025, EBITDA Margin fell 3426.0% year-over-year to 85.3%; the trailing twelve-month figure through Dec 2025 stood at 91.76% (down 250.0% YoY), and the FY2025 full-year result was 91.76%, down 3011.0% from the prior year.
- EBITDA Margin grew to 85.3% in Q4 2025, from 91.78% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 51.04% in Q4 2024 to a low of 230.37% in Q1 2022.
- A 5-year average of 131.47% and a median of 115.78% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin plunged 19791 bps in 2021 and soared 10147 bps in 2023, its largest moves.
- Tracing SOPH's EBITDA Margin over 5 years: stood at 192.09% in 2021, then soared by 41 bps to 112.69% in 2022, then surged by 37 bps to 71.25% in 2023, then advanced by 28 bps to 51.04% in 2024, then tumbled by 67 bps to 85.3% in 2025.
- Business Quant data shows SOPH's EBITDA Margin at 85.3% in Q4 2025, 91.78% in Q3 2025, and 100.92% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.50 Bn | 662.02 Mn | 30.93% |
| 2 | BrightSpring Health Services | 14.59 Bn | 13.69 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 8.32 Bn | 8.05 Bn | 256.31 Mn | 29.03% |
| 4 | Hinge Health | 5.97 Bn | 5.65 Bn | 154.23 Mn | 17.59% |
| 5 | 10x Genomics | 5.78 Bn | 5.24 Bn | 106.18 Mn | -11.30% |
| 6 | MiniMed | 4.53 Bn | 4.23 Bn | 480.00 Mn | -11.11% |
| 7 | Waystar Holding | 4.49 Bn | 4.42 Bn | 216.84 Mn | 25.64% |
| 8 | Doximity | 3.99 Bn | 3.24 Bn | 125.97 Mn | 17.08% |
| 9 | Privia Health | 3.18 Bn | 2.76 Bn | - | 1.23% |
| 10 | SOPHiA GENETICS | 391.73 Mn | 321.44 Mn | 14.69 Mn | -85.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -85.30% |
| Sep 30, 2025 | -91.78% |
| Jun 30, 2025 | -100.92% |
| Mar 31, 2025 | -90.20% |
| Dec 31, 2024 | -51.04% |
| Sep 30, 2024 | -96.91% |
| Jun 30, 2024 | -94.92% |
| Mar 31, 2024 | -118.87% |
| Dec 31, 2023 | -71.25% |
| Sep 30, 2023 | -101.48% |
| Jun 30, 2023 | -133.17% |
| Mar 31, 2023 | -138.10% |
| Dec 31, 2022 | -112.69% |
| Sep 30, 2022 | -202.94% |
| Jun 30, 2022 | -206.39% |
| Mar 31, 2022 | -230.37% |
| Dec 31, 2021 | -192.09% |
| Sep 30, 2021 | -197.91% |
| Jun 30, 2021 | -156.46% |
| Mar 31, 2021 | -156.57% |